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INTRODUCTION
Nuclear magnetic resonance (NMR) imaging has recently become an accepted
technique in the medical practitioner's armory (38). NMR spectroscopy (44) is a
subtly different application of the same physical principles underlying NMR im-
aging, but the clinical potential for this modality is currently still under evaluation.
The most important application of clinical NMR spectroscopy is for the nonin-
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vasive monitoring of changes in metabolite levels and intracellular pH of intact
tissues during physiological stress or in response to pharmacological agents or
disease. The 31phosphorus (3IP) nucleus has been the most commonly investigated
in muscle disease (39) but the applications of proton ('H), (4,5,8) and l3carbon
(I3C), (2,7) are currently being explored.
The main difference between NMR imaging and NMR spectroscopy is that
in the former, protons (mainly in water) are positionally labeled by the application
of magnetic field gradients so that the resonant frequency depends on the location
of the 'H nucleus in the tissue. By the use of suitable combinations of field gra-
dients, a three-dimensional proton distribution can be derived which can give an
image in any selected plane. In NMR spectroscopy, a highly homogeneous, static
magnetic field is applied to the sample. This enables the nuclei in different chem-
ical species to resonate at resolvable frequencies and so produce a spectrum. The
separation of signals from various chemical species is made possible by the fact
that each nucleus experiences a total magnetic field consisting of the main field
plus a local field depending on chemical structure, and hence the resonances are
chemicaly shifted and separated in the frequency spectrum.
The information acquired from NMR spectra consists of determinations of
relative metabolite concentrations from measurements of resonance line areas
and estimates of the intracellular pH from the chemical shifts of inorganic phos-
phate (Pi), (36) or the C4-H, C2-H, and N-H protons of carnosine (5).
The NMR method has some advantages over needle or open biopsy proce-
dures. Being noninvasive, harmless (42), and painless, NMR spectra can be col-
lected as frequently as the signal-to-noise ratio will allow, and the procedure is
acceptable to young children. The metabolites are assayed in situ, and it is believed
that realistic estimates are obtained (47), whereas using the needle biopsy pro-
cedure, even the most skilful operator takes a few seconds to obtain and freeze
the sample, allowing time for metabolite levels to change. Using NMR, typically
10 to 50 cm3 of tissue are examined, and the metabolite and pH results are more
representative of overall muscle pathology, whereas the fact that needle biopsy
gives only a small sample can be a problem in inhomogeneous tissue. Histological
information, however, is not obtained, and hence NMR spectroscopy augments
but does not replace the biochemical and histological uses of biopsy and other
techniques.
METHODS
There are some problems associated with the clinical use of NMR spectroscopy.
Practicalities concerning patient comfort while locating the muscle of interest in
the center of the magnet bore have to be dealt with (15). The limb has to be
adequately supported so that minimal pressure is applied to major blood vessels
or nerves, and it is essential that some method of limb restraint is available to
restrict movement. Studies of forearm muscle are usually made with the subject
sitting on a chair; investigations of the calf muscles require the provision of a
couch. The limb is usually grounded to reduce radio frequency (Rf) interference.
Usually one or two flexible, electrically conducting straps coated with contact
gel are used to ground the limb; however, an alternative approach is to completely
enclose the subject in a Faraday shield.
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In order to pick up the NMR signal, it has been found most practical to use
a surface coil antenna consisting of one or more loops of wire placed on the skin
adjacent to the tissue of interest (1). The surface coil is used for pulse transmission
to perturb the nuclei as well as for reception of the subsequent free induction
decay (FID). Insulation between the patient and the coil is usually provided by
a thin (approximately 1 mm) sheet of polytetrafluoroethylene (PTFE). Coils are
tuned to the Rf for the particular nucleus and matched to the appropriate imped-
ance while the limb is in position. The addition of a simple circuit allows the same
coil to be "double tuned" for 'H, and this allows the homogeneity of the main
field to be optimized (shimmed) using the strong H2O signal. Both these tasks can
be accomplished usually within 5 minutes. Parameters such as coil size and tuning
(15), pulse length (related to flip angle), and pulse interval also need to be opti-
mized to get maximum signal per unit time (23,31). For short pulse intervals,
correction factors have to be determined for each metabolite to allow for insuf-
ficient relaxation of the spin system between pulses. These factors can be esti-
mated usually by collecting data with the normal pulse interval and then with a
pulse interval several times the longest Tl (the spin-lattice relaxation time con-
stant) so that the spin system is very nearly relaxed. Direct comparison of the
resonance line areas then gives correction factors which can be applied to all
subsequent data.
The signal has to be localized so that data are acquired only from the required
tissue, and this can be achieved in several ways. The spatial sensitivity of circular
surface coils as a function of flip angle and pulse repetition rate has been examined
in detail (23,31). A degree of localization can be obtained by judicious positioning
of the coil adjacent to the muscle and by appropriate selection of the transmitted
pulse length, interval, or sequence (9,10,11). For 31P-NMR investigations, great
benefit is obtained from the fact that most surface tissues do not contain detectable
amounts of phosphorus metabolites, and simple muscle studies can be made by
the use of a suitable size surface coil only. An alternative approach is to super-
impose high-order profiled magnetic field gradients onto the main field (25), which
are arranged so that only a defined volume of muscle experiences a homogeneous
field. Nuclei in the field gradients resonate over a range of frequencies, and this
broad signal can be removed by mathematical processing (26) to leave only the
narrow resonance lines from the homogeneous region. In studies of muscle, signal
localization has so far been achieved by the use of combinations of all these
methods.
At the moment, techniques involving the application of field gradients are
being developed to give the user more flexible localization and ability to define
the shape, size, and position of the volume from which data is collected (6,12,43).
These methods are somewhat handicapped by the low concentrations and sen-
sitivities of most potentially interesting nuclei. For muscles near to the skin sur-
face, the user may still be better off in many applications using the simple surface
coil technique.
If it is desired to localize the signal to a particular, deeper muscle, then more
sophisticated techniques have to be applied in order to reduce signals from tissues
closer to the coil. If I3C or 'H are studied, then some method of avoiding data
contamination by signals from skin or subcutaneous fat has to be used. Studies
using these two nuclei encounter other problems. Because of the magnetic struc-
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Figure 1. (a) 'H spectrum obtained using a 2.5 cm diameter coil placed adjacent
to the extensor digitorum muscle. 8 x 75 (is pulses with a pulse interval of 1.256
s. The main peak is due to H2O protons; the other smaller resonances are due
mainly to subcutaneous fat. (b) A 13C spectrum collected with a 4 cm surface coil
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ture of organic molecules, I3C spectra usually consist of resonance line multiplets
which complicate spectral analysis. These multiplets can be condensed to single
resonances by simultaneously applying decoupling Rf at the 'H frequency. How-
ever, as this can cause tissue heating, the use of decoupling has to be approached
very cautiously in living systems. 'H studies of tissue are handicapped by the
presence of a very large H2O resonance which completely dominates the spec-
trum. Various pulse sequence techniques exist for the reduction of this signal
(33,40) although their usefulness with surface coils remains to be shown. The
application of 'H-NMR to muscle shows great promise because of the greater
sensitivity of the proton and the large number of potentially detectable metabolites
including lactate, phosphocreatine (PCr), and creatine (4,5).
CLINICAL APPLICATIONS OF NMR SPECTROSCOPY TO
MUSCLE DISEASE
Normal Muscle
In order to use NMR spectroscopy to monitor physiological or pathological
changes in muscle tissue, it is necessary to know the normal ranges for resting
metabolite levels and intracellular pH. Figures 1 and 2 show 'H, 13C, and 31P
spectra obtained from normal, resting muscles. The 'H spectrum (Figure la) con-
sists mainly of a strong H2O resonance and a small peak due to -CH2 protons in
triglycerides. Other resonances from metabolites of millimolar concentration such
as creatine, phosphocreatine, and lactic acid are swamped by the strong H2O and
-CH2 signals. If no precautions are taken to reduce surface tissue signals, the
size of this -CH2 proton peak will depend largely on the subcutaneous fat thick-
ness. In the coupled I3C spectrum (Figure lb), the predominant feature is the
triplet, due to -CH2 carbon nuclei in triglyceride chains. Other prominent reso-
nances are detected from -CH3, Glycerol, - O C - , and RCOOR' carbons. So far,
the most illuminating results from muscle tissue have been obtained using 3 I P
NMR. The spectrum from normal, resting extensor digitorum (Figure 2) shows
several prominent resonances from ATP (the 7-, a-, and (3-phosphorus nuclei),
phosphocreatine (PCr), and inorganic phosphate (Pi). Signals from monoesters
(mainly sugar-phosphates (SP) and phosphodiesters (PD) are also detected along
with broad signals from immobile phosphorus in bone and phospholipids which
in this spectrum have been removed mathematically to give a flat baseline. The
PCr resonance usually has a very good signal-to-noise ratio and is commonly used
as an internal reference for the determination of 3IP-NMR chemical shifts. The
PCr line profile is narrow and its chemical shift is not pH dependent, although
there is some variation with the Mg2+ concentration. In most muscle studies the
PCr resonance makes a good reference. However, in instances of PCr depletion,
placed on the belly of the calf. No proton decoupling was used. 512 x 40 jxs
pulses with an interval of 1.256 s. The spectrum probably contains a significant
amount of contamination from subcutaneous fat tissue. The prominent triplet at
the right-hand end of the spectrum is due to the carbon nuclei in triglyceride
chains. Spectrum [a] obtained with the assistance of N. Taylor.
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Figure 2. A 3IP spectrum obtained from the extensor digitorum muscle using the
same coil as in Figure la. 256 x 13 (xs pulses with an interval of 2.256 s. Because
of the very low concentrations of mobile 3IP metabolites in other adjacent tissues,
metabolite levels determined from this spectrum are very close to those pertaining
to the muscle tissue. Spectrum obtained with the assistance of N. Taylor.
it may be necessary to use other approaches, such as 'H H2O referencing (17).
Mean values for the metabolite levels (relative to a total mobile and NMR-visible
phosphate pool of 1) and pH of normal, resting, male calf muscle tissue are given
in Table 1 (28).
Changes in normal metabolite levels and pH can be induced by ischemia (19)
or exercise (46), and time resolution better than a minute can usually be obtained
using the NMR technique. Figure 3 shows the response of muscle tissue to oc-
clusion of arterial blood flow to the arm by a sphygmomanometer cuff for 35
minutes. Gradual depletion of PCr and increase of Pi occurs until the cuff is
released. PCr + Pi, ATP, and pH appear to stay constant throughout the study.
Metabolite changes can also be monitored during exercise, which for the
subject can consist of squeezing an air bladder, moving a lever, or making iso-
metric contractions, with a strain gauge to record the performance. Exercise can
be continuous or prompted repeatedly by a signal synchronized to the Rf trans-
mitted pulse, so that data are acquired only in the interval between contractions.
Several resting spectra are obtained at first as a baseline followed by exercise
spectra until sufficient changes have been observed. Exercise is then stopped and
the recovery of metabolite levels and pH to the original resting levels is followed
by collecting further spectra. Modern spectrometers with computer control have
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Table 1. Metabolite Ratios (Relative to Total Mobile Phosphate) for
Normal Calf, Forearm, and Duchenne Dystrophy Calf.
P-ATP
PCr
Pi
P-diester
PCr/ATP
PCr/Pi
PCr + Pi
PH
Normal
n =
(Mean)
0.11
0.47
0.08
0.06
4.23
6.02
0.55
7.05
Calf
5
(SD)
0.01
0.02
0.01
0.02
0.12
0.49
0.03
0.03
Normal
n =
(Mean)
0.11
0.49
0.08
0.03
4.44
6.71
0.57
7.04
Forearm
 24
(SD)
0.01
0.03
0.01
0.02
0.49
1.54
0.03
0.05
Duchenne
Dystrophy Calf
n =
(Mean)
0.11
0.39a
0.14a
0.06
3.7Oa
2.92a
0.53
7.08
53
(SD)
0.02
0.04
0.03
0.02
0.75
0.81
0.03
0.10
" Significant difference (p < .001) between normal and Duchenne calf.
the ability to run complete studies of this type with minimal operator intervention.
Figure 4 shows the response of normal muscle tissue to a typical exercise test.
PCr is rapidly consumed with accompanying accumulation of Pi and fall in pH
due to lactate accumulation from glycolysis. Recovery of metabolites and pH to
resting values is complete within about 5 minutes. Studies of normal exercizing
muscle tissue in young and old populations have shown no significant differences,
indicating that muscle changes in the elderly are not due to alterations in energy
production (45).
Duchenne Muscular Dystrophy
A large amount of attention has been focused on the application of NMR spec-
troscopy to muscular dystrophy, and in particular to Duchenne dystrophy
(16,22,28,29,37). Table 1 shows the mean resting metabolite levels and pH as
determined by 3IP-NMR and indicates significant differences between values for
PCr, Pi, PCr/Pi, and PCr/ATP when compared with age matched normals. The
decrease in PCr/Pi ratio to 50% and PCr/ATP ratio to 90% of the normal resting
values in the presence of a normal H + concentration could be related to changes
in the creatine or ADP concentrations or the effectiveness of oxidative phos-
phorylation, perhaps in only some of the muscle fibers. A difference in resting
pH has been reported (37), but this may be due to technique or the investigation
of subjects with more advanced disease. Exercise studies have been performed
on the forearm muscles of a seven-year-old boy with Duchenne dystrophy (28).
Although exercise started from an initially reduced PCr and increased Pi level,
during recovery PCr rose and Pi fell to the starting levels quite rapidly, indicating
normal activity of the enzyme creatine kinase and normal mitochondrial function.
This suggests that the altered resting metabolite levels do not prevent normal
muscle activity and that fiber loss rather than reduction in "high energy" phos-
phates causes the muscle weakness as previously emphasized in needle biopsy
studies (21).
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Figure 3. Changes in 3IP metabolites and pH in normal resting forearm muscle
induced by occlusion of the arterial blood supply. Spectra were collected using
a 6 cm surface coil placed over the forearm flexor muscle compartment. The pulse
length was optimized for maximum signal: 32 pulses, pulse delay 2.256 s.
Other Myopathies
Abnormal resting muscle spectra have been seen in only a few cases of myopathy
apart from muscular dystrophy. The abnormalities reveal themselves as decreased
PCr/Pi ratios (24,39), a reported increase in phosphodiester signal in hypothyroid
myopathy (34) or alkaline pH (39). Exercise studies produce more interesting
results.
Several cases of phosphofructokinase (PFK) deficiency have been examined
(18,22,30). Although resting metabolite levels and pH are normal, exercise leads
to the detection by 31P-NMR of rapid accumulation of fructose-6-phosphate, a
metabolite in the glycolytic pathway (see Figure 5). No significant change in pH
has been reported in any study confirming the inability to produce lactic acid. On
cessation of exercise, there is a slow recovery of PCr to the resting level. This
could be due to the trapping of phosphate by fructose-6-phosphate generated by
the enzyme block.
Another more common, but still rare, disorder is McArdle's syndrome (myo-
phosphorylase deficiency), in which the patient is unable to utilize glycogen for
NUCLEAR MR SPECTROSCOPY AND HUMAN MUSCLE METABOLISM 639
pH •«—Resting
7.0 -J
6 . 5 -
Recovery
15 Time (min.)
Figure 4. Response of normal muscle tissue to anaerobic contractions. During
the exercise regime the arterial circulation was occluded by the application of a
sphygmomanometer cuff controlled by compressed air. Exercise consisted of 32
x 1 sec. 20% maximum isometric voluntary contractions interleaved with data
acquisition every 2.256 sec. Subject performance was monitored by the use of a
strain gauge applied to the back of the hand. On alternate data collections the
muscle was relaxed. At the end of the complete exercise sequence the cuff was
let down and the metabolite levels allowed to recover. Conditions of data col-
lection as for Figure 3. Metabolite concentrations were estimated using a total
mobile phosphate concentration of 49.5 mmol. kg"1 wet wt. Source: Reference
20.
anaerobic glycolysis because of a deficiency of the enzyme phosphorylase. This
has been studied in four patients using 31P-NMR (39,41). The resting metabolite
levels were normal, and average resting pH was 7.05. During exercise there was
a marked decrease in PCr and an increase in Pi—but no intracellular acidosis—
in the patients with McArdle's syndrome, while in normal subjects pH decreased
significantly due to lactic acid production. In fact, during exercise in the my-
ophosphorylase-deficient muscle, pHs were consistently alkaline and could be
estimated very well because of the high Pi and PCr signal-to-noise ratios.
A case of postviral myopathy following chickenpox has recently been inves-
tigated (3). The study revealed a very rapid intracellular acidosis on exercise and
subsequently a slower than normal recovery of PCr to the resting level while pH
recovered at the normal rate. The excess acidosis could have been caused by
increased lactic acid production, reduced buffering capacity, or abnormal elimi-
nation of acid from the cytosol. Because of the normal pH late in the exercise
protocol and the normal rate of pH recovery, it has been suggested that the ab-
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Figure 5. 31P NMR spectrum of phosphofructokinase- (PFK) deficient forearm
muscle during aerobic exercise. Note the greatly increased sugar phosphate peak
at about 7 ppm due mainly to the accumulation of unmetabolized fructose-6-
phosphate. Data acquisition conditions as for Figure 3, but 64 pulses. The peak
assignments are as for Figure 2.
normality may be due to a change in the relative contributions of glycolytic and
oxidative processes. A low general mitochondrial activity in subjects with muscle
pain has been described (35), and this therefore is not too surprising.
Hypothyroid myopathy has been investigated in two subjects. In one case, a
raised phosphodiester level was reported (34), but in the other case (30), no sig-
nificant abnormality at rest or during exercise and recovery was shown both before
and 6 weeks after commencement of thyroxine, despite the subjects' regaining
normal muscle function.
In a large number of patients with undiagnosed muscular pain and fatigue
during or after exercise 31P-NMR has so far not shown any abnormality in spite
of the possibility of energy supply defects. One group reports that out of 68 such
cases, only 20% have shown a deviation from normal NMR results (39).
Monitoring Chemotherapy
Clinical NMR offers the possibility of monitoring the response of in situ tissue to
therapeutic regimes. Of particular importance is the cytotoxic response of malig-
nant tissue to chemotherapy; the noninvasive nature of NMR is ideally suited to
this function. So far only one in situ malignant tumor (that of muscle, a rhab-
domyosarcoma) has come under scrutiny (27). The 31P-NMR spectra from the
tumor (see Figure 6) taken at the start and end of a six week course of chemo-
therapy were very different from a spectrum taken from a healthy volunteer which
mainly represented interosseus muscle and was similar in appearance to Figure 2.
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Figure 6. 31 P-NMR spectra of a malignant tumor of muscle tissue (a rhabdomy-
osarcoma) taken before and after a course of chemotherapy. Spectra were col-
lected using a 4 cm surface coil placed directly over the 5 cm long, 3.5 cm wide,
1 cm deep tumor on the dorsal surface of the hand. Each spectrum resulted from
the sum of 512 free induction decays with a pulse interval of 2.5 s and a 24 (xs
pulse length giving optimum signal from 31P nuclei close to the coil. Legend: 1—
phosphomonoester; 2—inorganic phosphate; 3—phosphodiester; 4—phospho-
creatine; 5—7-ATP; 6—a-ATP; and 7—(J-ATP. It is possible that peaks 5 to 7
contain contributions from other di- and trinucleotides as well as NAD and NADH
(peak 6).
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The most striking features were the presence of conspicuous peaks in the phos-
phomonoester and diester regions of the spectra and reduced PCr/Pi and PCr/
ATP ratios when compared with the normal subject's. The only differences be-
tween the tumor spectra before and after treatment were reductions in PCr/ATP
to 75% and PCr/Pi to 70% of their initial values. In accord with the overall clinical
situation and the absence of tumor resorption, this was taken to indicate deteri-
oration. The ability to follow such changes indicates the potential for monitoring
the effect of different cytotoxic chemotherapeutic regimes.
FUTURE DEVELOPMENT OF CLINICAL NMR
SPECTROSCOPY FOR MUSCLE STUDIES
The more general application of NMR spectroscopy to muscle disease must be
considered in the light of some of the other major clinical applications. 31P-NMR
spectroscopy has already made a significant contribution to the study of neonatal
cerebral metabolism (14,32,48). Further advances in the investigation of the brain
and other organs in adults and children will require the use of large-bore whole-
body spectrometers which are recently available. Systems are also being devel-
oped to combine NMR imaging and spectroscopy (13). The considerable invest-
ment of financial and personnel resources in the management of a clinical NMR
system will depend on its application to a broad medical horizon including both
imaging and spectroscopy of many different organs. However, advantages arise
from experience gained in studying other tissues, particularly in terms of the
optimization of signal localization and sensitivity.
At present, the use of NMR in the study of muscle and other tissues is hand-
icapped to some extent by the reliance on surface coil techniques. The devel-
opment of methods by which the operator can know fairly precisely the location
and shape of the tissue volume from which the NMR signal originates will be very
beneficial. Some sensitivity problems are encountered when investigating deeper
tissues. These may be avoided in the future if the potential of 'H NMR is realized,
especially if studies of the safety of NMR allow the introduction of higher magnet
field strengths and hence better resolution and signal-to-noise ratios. The variety
of metabolites that are available for study by 'H-NMR may make it unnecessary
to use other nuclei in general, although there will always be special applications.
Several NMR systems offer the facilities of imaging (based on 'H) together
with spectroscopy and will be of potential value in identifying more precisely the
sensitive volume from which biochemical measurements are made. A further de-
velopment which is in sight is the possibility of imaging with individual phospho-
rus-containing metabolites so as to give the topography of tissue biochemistry.
The application to a myopathy would be to identify damaged and diseased volumes
of muscle as well as the study of the homogeneity of energy exchanges in different
parts of a muscle during its contraction. This has particular relevance to con-
tracture development in patients with the glycolytic disorders already mentioned
(McArdle's syndrome and phosphofructokinase deficiency), and such application
may give diagnostic information in a wider range of causes of unexplained muscle
pain.
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